Femasys Inc (FEMY)

Currency in USD
0.6253
-0.0247(-3.80%)
Closed·
0.6227-0.0026(-0.42%)
·
FEMY is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.60010.6499
52 wk Range
0.30671.8000
Key Statistics
Prev. Close
0.65
Open
0.647
Day's Range
0.6001-0.6499
52 wk Range
0.3067-1.8
Volume
856.5K
Average Volume (3m)
4.32M
1-Year Change
-45.6261%
Book Value / Share
0.11
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FEMY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.1667
Upside
+726.27%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market

Femasys Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Femasys Inc Company Profile

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs in the United States and internationally. The company offers FemaSeed, an intratubal insemination solution; FemVue, a companion diagnostic for fallopian tube assessment through ultrasound; FemCerv, an endocervical tissue sampler for cervical cancer diagnosis; FemCath, a cornual balloon catheter for selective fallopian tube evaluation; and FemChec, a controlled contrast-generating device for fallopian tube diagnosis. It also develops FemBloc, a non-surgical permanent birth control solution. The company offers its products to reproductive endocrinologists, gynecological physicians, related healthcare professionals, and women’s healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Compare FEMY to Peers and Sector

Metrics to compare
FEMY
Peers
Sector
Relationship
P/E Ratio
−1.9x−3.3x−0.6x
PEG Ratio
−0.100.230.00
Price/Book
8.1x3.9x2.6x
Price / LTM Sales
18.0x3.4x3.4x
Upside (Analyst Target)
-33.1%41.5%
Fair Value Upside
Unlock6.8%4.4%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 5.1667
(+726.27% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Laidlaw
Buy6.50+939.50%-New CoverageNov 20, 2025
H.C. Wainwright
Buy12.00+1,819.08%-MaintainJun 26, 2025
Jones Trading
Buy6.00+859.54%10.00MaintainMay 13, 2025
H.C. Wainwright
Buy12.00+1,819.08%15.00MaintainMay 09, 2025
H.C. Wainwright
Buy15.00+2,298.85%-MaintainMar 28, 2025

Earnings

Latest Release
Nov 14, 2025
EPS / Forecast
-0.10 / -0.1267
Revenue / Forecast
729.39K / 2.09M
EPS Revisions
Last 90 days

FEMY Income Statement

People Also Watch

16.480
BNAI
+90.30%
0.6771
ATON
-8.50%
0.566
VCIG
-2.92%
1.4800
CHR
-5.73%

FAQ

What Is the Femasys (FEMY) Stock Price Today?

The Femasys stock price today is 0.6253

What Stock Exchange Does Femasys Trade On?

Femasys is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Femasys?

The stock symbol for Femasys is "FEMY."

What Is the Femasys Market Cap?

As of today, Femasys market cap is 37.13M.

What Is Femasys's Earnings Per Share (TTM)?

The Femasys EPS (TTM) is -0.67.

When Is the Next Femasys Earnings Date?

Femasys will release its next earnings report on Mar 26, 2026.

From a Technical Analysis Perspective, Is FEMY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Femasys Stock Split?

Femasys has split 0 times.

How Many Employees Does Femasys Have?

Femasys has 70 employees.

What is the current trading status of Femasys (FEMY)?

As of Jan 25, 2026, Femasys (FEMY) is trading at a price of 0.6253, with a previous close of 0.6500. The stock has fluctuated within a day range of 0.6001 to 0.6499, while its 52-week range spans from 0.3067 to 1.8000.

What Is Femasys (FEMY) Price Target According to Analysts?

The average 12-month price target for Femasys is USD5.1667, with a high estimate of USD6.5 and a low estimate of USD3. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +726.27% Upside potential.

What Is the FEMY After Hours Price?

FEMY's last after hours stock price is 0.6227, the stock has decreased by -0.0026, or -0.4200%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.